(Q44193447)

30 November 2017

0 references

Lessons learned from the valsartan- heart failure trial (Val-HeFT): angiotensin receptor blockers in heart failure (English)

1 reference

30 November 2017

0 references

1 reference

Jay N Cohn

1

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

American Journal of Cardiology

30 November 2017

published in

1 reference

30 November 2017

volume

90

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

992-993

1 reference

Cardiac failure: a revised paradigm

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902667-X

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902667-X

Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902667-X

Angiotensin II and trials of cardiovascular outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902667-X

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902667-X

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902667-X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902667-X

Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902667-X

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902667-X

Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure. Vasodilator Heart Failure Trial (V-HeFT) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902667-X

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902667-X

10.1016/S0002-9149(02)02667-X

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference